Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Saccharin)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST000923 AN001514 Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease Feces Human Inflammatory bowel disease The Broad Institute Abundance
ST000923 AN001515 Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease Feces Human Inflammatory bowel disease The Broad Institute Abundance
ST001000 AN001879 Gut microbiome structure and metabolic activity in inflammatory bowel disease Feces Human The Broad Institute Abundance
ST001192 AN001986 A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research Feces Human The Broad Institute Abundance
ST002470 AN004031 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling Blood Human Ulcerative colitis Broad Institute of MIT and Harvard Abundance
ST002470 AN004032 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling Blood Human Ulcerative colitis Broad Institute of MIT and Harvard Abundance
ST002471 AN004035 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling Feces Human Ulcerative colitis Broad Institute of MIT and Harvard Abundance
ST002471 AN004036 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling Feces Human Ulcerative colitis Broad Institute of MIT and Harvard Abundance
ST002247 AN003673 Microbiota and Health Study (Dhaka, Bangladesh) Feces Human Broad Institute of MIT and Harvard Abundances
ST003438 AN005652 Unbiased genetic screening and metabolomics identifies glial adenosine metabolism as a therapeutic target in Parkinson’s disease Fly Head Fly Parkinson's Disease Broad Institute of MIT and Harvard Abundances
ST002328 AN003797 Metabolome and transcriptome analysis of oral mucosa of HIV+ patients reveal a role for polyamine metabolic pathway in T cell dysfunction Saliva Human HIV Case Western Reserve University area
ST002328 AN003798 Metabolome and transcriptome analysis of oral mucosa of HIV+ patients reveal a role for polyamine metabolic pathway in T cell dysfunction Saliva Human HIV Case Western Reserve University area
ST002758 AN004476 Metabolic responses of normal rat kidneys to a high salt intake (Plasma) Blood Rat Medical College of Wisconsin Area
ST002283 AN003729 The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains Bone Human University of Central Lancashire Area integration
ST003327 AN005451 Control Of Major Bleeding After Trauma (COMBAT) Clinical Research Trial Metabolomics Blood Human Trauma University of Colorado Anschutz Medical Campus area under curve
ST001639 AN002683 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health AU
ST003434 AN005641 Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. Blood Human Cancer Wistar Institute Counts per second (cps)
ST003435 AN005643 Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 Media, Metabolite extract Zebra fish Cancer Wistar Institute Counts per second (cps)
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Brain, Heart, Liver, Blood Mouse Cancer Wistar Institute Counts per second (cps)
ST002155 AN003530 Longitudinal metabolomic stool dynamics in primary C. difficile infections Feces Human Bacterial infection Brigham Women's Hospital intensity
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST002020 AN003290 TIPs Metabolomics (urine) Urine Human Vanderbilt University Medical Center osmolality normalized scaled imputed
ST002498 AN004656 Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort Blood Human Cancer Weill Cornell Medicine peak area
ST001411 AN002361 Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark Blood Human Obesity University of Michigan Peak area
ST001412 AN002362 Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures Blood Human Obesity University of Michigan Peak area
ST002909 AN004777 Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis Blood Human Melioidosis University of Washington Peak Area
ST001937 AN003150 Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules Blood Human Cancer China Pharmaceutical University peak height
ST002698 AN004373 Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites Infected Red Blood Cells Plasmodium berghei Malaria Peter Doherty Institute for Infection and Immunity peak height
ST000421 AN000664 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000668 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000899 AN001464 Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling Blood Human Inflammatory bowel disease Vanderbilt University Medical Center raw area counts
ST001400 AN002341 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria Blood Human Malaria New York University Abu Dhabi raw area counts
ST001516 AN002516 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) Blood Human Malaria New York University Abu Dhabi raw area counts
ST001517 AN002519 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) Blood Human Malaria New York University Abu Dhabi raw area counts
ST001749 AN002850 REACH Metabolomics Study Blood Human Alzheimers disease University of Wisconsin - Madison Raw area counts
ST002818 AN004588 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002819 AN004592 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002820 AN004596 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST001683 AN002747 A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. Blood Mouse Stanford University Raw ion count (peak area)
ST001683 AN002747 A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. Feces Mouse Stanford University Raw ion count (peak area)
ST001683 AN002747 A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. Intestine Mouse Stanford University Raw ion count (peak area)
ST001683 AN002747 A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. Urine Mouse Stanford University Raw ion count (peak area)
ST003131 AN005137 Untargeted Metabolomics on mouse caecal contents Cecum Mouse University College Cork Raw Peak Area
ST001849 AN002994 Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity (part I) Blood Human COVID-19 Washington University, St. Louis Relative Intensity
ST002088 AN003408 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health relativeMedian
ST002089 AN003412 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health relativeMedian
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST002018 AN003288 Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) Feces Human Vanderbilt University Medical Center scaled imputed
ST002019 AN003289 TIPs Metabolomics (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST000974 AN001595 GC6-74 matabolomic of TB (Part 1: Plasma) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST000975 AN001596 GC6-74 metabolomics of TB vs healthy (Part 2: Serum) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST000976 AN001597 GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST002246 AN003669 Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study Feces Human Broad Institute of MIT and Harvard Unitless Abundances
ST001519 AN002528 Stool metabolites of known identity profiled using hybrid nontargeted methods (part-I) Feces Human Broad Institute of MIT and Harvard unitless peak areas
ST001521 AN002536 Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) Blood Human Broad Institute of MIT and Harvard unitless peak areas
  logo